Background This meta-analysis evaluated the real-world effectiveness of
onabotulinumtoxinA (BOTOX®), the first preventive treatment FDA-approved specifically for …

Background. Chronic headache (CH) is a condition that includes different subtypes of
headaches and that can impair different life domains. Personality traits can play a relevant …

Objective Previous studies have demonstrated that emotional stress, changes in lifestyle
habits and infections can worsen the clinical course of migraine. We hypothesize that …

Introduction Numerous medications are used for the preventive treatment of chronic
migraine (CM), including oral treatments, onabotulinumtoxinA (onabotA; BOTOX), and …

This explorative cross-sectional study aims at exploring emotional distress, psychological
profiles, and the attitude towards receiving psychological support in eighty-seven patients …

Background Migraine is common in primary headaches, and with the development of social
economy and the increase in living pressure, the prevalence of migraine has an upward …

Background Face-to-face procedures have been postponed during COVID-19 pandemic.
We aim to evaluate the impact of onabotulinumtoxinA follow-up delay in migraine during …

Migraine, marked by moderate to severe headaches, is frequently accompanied by
reversible neurological symptoms. Recent studies have revealed a complex and significant …

Si bien es cierto que la migraña nace con la especie humana, y las primeras descripciones
aparecen en la cultura sumeria, la importancia que la sociedad le ha brindado a esta …

En el mundo, la migraña afecta al 12% de la población, lo que en Chile representa un total
de 2.200. 000 pacientes, cantidad muy significativa y que, además, conlleva gastos …